QUÉBEC CITY, Aug. 6, 2014 /CNW
Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ)
(the "Company") today announced that the Company's Chairman,
CEO, David Dodd, will be presenting
a corporate overview at the Canaccord Genuity 34th Annual Global
Growth Conference on Wednesday, August 13,
2014, at 1pm (Eastern), in the
Melbourne Room of the Intercontinental Hotel in Boston.
A live audio and slide webcast of the presentation will be
available via the Company's website at www.aezsinc.com in the
"Newsroom" section, under "Events and Webcasts". A replay of the
webcast will also be available on the Company's website for a
period of 90 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel treatments in
oncology and endocrinology. The Company's pipeline encompasses
compounds at various stages of development. For more information,
visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.